Your browser doesn't support javascript.
loading
Electromagnetic interference complicating Impella® use during pediatric ablation.
Sullivan, John S; Maitoza, Laura A; Brysiewicz, Neil R; Hall, E Kevin; Beach, Cheyenne M.
Afiliação
  • Sullivan JS; Department of Pediatrics, Yale New Haven Children's Hospital, New Haven, CT, USA.
  • Maitoza LA; Department of Pediatrics, UCLA Mattel Children's Hospital, Los Angeles, CA, USA.
  • Brysiewicz NR; Section of Cardiovascular Medicine, Division of Medicine, Yale New Haven Hospital, 20 York Street, New Haven, CT, USA.
  • Hall EK; Department of Pediatrics, Section of Pediatric Cardiology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT, USA.
  • Beach CM; Department of Pediatrics, Section of Pediatric Cardiology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT, USA.
Ann Pediatr Cardiol ; 15(5-6): 533-535, 2022.
Article em En | MEDLINE | ID: mdl-37152518
In children, the Impella® is most commonly used in the setting of cardiogenic shock. There are few reported cases of Impella® use in pediatric patients undergoing ablation; description of troubleshooting techniques may improve success rates. We describe a pediatric patient with tachycardia-induced cardiomyopathy due to incessant ectopic atrial tachycardia whose ablation was notable for significant electromagnetic interference (EMI) from the Impella® leading to incomplete mapping. This case highlights the need for multidisciplinary planning and consideration of possible EMI with the use of magnet-based electroanatomic mapping systems as well as troubleshooting techniques to reduce the impact of EMI.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article